2019 HSC Section 2 - Practice Management

TABLE VI. Sensitivity Analysis (volume).

Cidex OPA †

Revital-Ox ‡

Tristel Trio Wipe §

STERIS System 1*

1,040 events (5/day) Consumable cost

$9.49

$9.44

$7.06

$7.31

Labor cost

$2.22

$2.59

$2.04

$2.04

Repair cost

$5.86

$3.67

$3.79

$3.79

Capital cost

$12.90

$13.34

$0.38

NA

Total cost per event

$30.47

$29.04

$13.27

$13.14

6,240 events (30/day) Consumable cost

$9.25

$6.55

$5.40

$7.31

Labor cost

$2.22

$2.59

$2.04

$2.04

Repair cost

$5.86

$3.67

$3.79

$3.79

Capital cost

$2.15

$2.22

$0.06

NA

Total cost per event

$19.48

$15.03

$11.29

$13.14

*STERIS System 1: Steris Canada Inc., Mississauga, Canada. † Cidex OPA: Advanced Sterilization Products, Johnson and Johnson Inc., Markham, Canada.

‡ Revital-Ox: Steris Canada Inc., Mississauga, Canada. § Tristel Trio Wipe System: Tristel plc, Cambridgeshire, U.K. $ 5 Canadian Dollars; NA 5 not applicable; OPA 5

ortho-phthalaldehyde.

The Revital-Ox (Steris Canada Inc.) reprocessing system was demonstrated to be the most cost-effective system examined. A significant cost savings could be afforded almost immediately by changing systems from the Steris system (Steris Canada Inc.), but change may be difficult to implement due to the continued push toward over-reprocessing via sterilization. With a soak- ing time of 5 minutes versus 23 minutes for the Steris (Steris Canada Inc.) cycle and 30 minutes for the Cidex OPA (Advanced Sterilization Products) cycle, this also would result in minimal nasopharyngoscope downtime and improved clinic efficiency. The cost minimization for Revital-Ox (Steris Canada Inc.) is even greater as reprocessing volumes increase. The AER system using Cidex OPA (Advanced Steril- ization Products) was substantially less expensive than

holds true across the scenario and sensitivity analysis. One advantage of Steris AER (Steris Canada Inc.) proc- essing is that it allows for little variation from protocol. It also technically is classified as a sterilization process rather than as a high-level decontamination, meeting the suggestion of preference for sterilization. 3 The increased complexity, however, increases the number of variables and components that require monitoring and testing to ensure that no bacterial colonization has occurred. There also is a real increase in both the num- ber of repairs required and the NPs necessary to run a clinic. At hospital S, 10 NPs were purchased in 2013 to help improve clinic volume in the face of the significant turnaround time for NP reprocessing. This would not have been necessary with the manual methods for reprocessing examined in this article.

TABLE VII. Scenario Analysis (capital cost) Per Event.

Cidex OPA †

Revital-Ox ‡

Tristel Trio Wipe §

STERIS System 1*

Consumable cost

$9.27

$4.60

$3.65

$7.31

Labor cost

$2.22

$2.59

$2.04

$2.04

Repair cost

$5.86

$3.67

$3.79

$3.79

Capital cost

$3.23

$3.34

$0.09

$0.00

Base case cost

$20.58

$14.20

$9.57

$13.14

Whole capital cost borne by OTO–HNS Capital cost

$6.63

$6.85

$0.09

$0.00

Total cost per event

$23.98

$17.71

$9.57

$13.14

No capital equipment cost to OTO–HNS Total cost per event

$17.35

$10.86

$9.57

$13.14

*STERIS System 1: Steris Canada Inc., Mississauga, Canada. † Cidex OPA: Advanced Sterilization Products, Johnson and Johnson Inc., Markham, Canada.

‡ Revital-Ox: Steris Canada Inc., Mississauga, Canada. § Tristel Trio Wipe System: Tristel plc, Cambridgeshire, U.K. $ 5 Canadian Dollars; NA 5 not applicable; OPA 5

ortho-phthalaldehyde; OTO–HNS 5

otolaryngology–head and neck surgery.

Laryngoscope 128: January 2018

Sowerby and Rudmik: A Cost Analysis of NP Reprocessing Techniques

187